These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 38403509

  • 1. Comparison of Empiric Antibiotic Treatment Regimens for Hospitalized, Non-severe Community-acquired Pneumonia: A Retrospective, Multicenter Cohort Study.
    Reeves SD, Hartmann AP, Tedder AC, Juang PA, Hofer M, Kollef MH, Micek ST, Betthauser KD.
    Clin Ther; 2024 Apr; 46(4):338-344. PubMed ID: 38403509
    [Abstract] [Full Text] [Related]

  • 2. Effect of β-Lactam Plus Macrolide Versus Fluoroquinolone on 30-Day Readmissions for Community-Acquired Pneumonia.
    Gilbert TT, Arfstrom RJ, Mihalovic SW, Dababneh AS, Varatharaj Palraj BR, Dierkhising RA, Mara KC, Lessard SR.
    Am J Ther; 2020 Apr; 27(2):e177-e182. PubMed ID: 30418221
    [Abstract] [Full Text] [Related]

  • 3. Comparative effectiveness of empiric β-lactam monotherapy and β-lactam-macrolide combination therapy in children hospitalized with community-acquired pneumonia.
    Ambroggio L, Taylor JA, Tabb LP, Newschaffer CJ, Evans AA, Shah SS.
    J Pediatr; 2012 Dec; 161(6):1097-103. PubMed ID: 22901738
    [Abstract] [Full Text] [Related]

  • 4. Fluoroquinolones or macrolides alone versus combined with β-lactams for adults with community-acquired pneumonia: Systematic review and meta-analysis.
    Raz-Pasteur A, Shasha D, Paul M.
    Int J Antimicrob Agents; 2015 Sep; 46(3):242-8. PubMed ID: 26092096
    [Abstract] [Full Text] [Related]

  • 5. Comparison of beta-lactam and macrolide combination therapy versus fluoroquinolone monotherapy in hospitalized Veterans Affairs patients with community-acquired pneumonia.
    Lodise TP, Kwa A, Cosler L, Gupta R, Smith RP.
    Antimicrob Agents Chemother; 2007 Nov; 51(11):3977-82. PubMed ID: 17709460
    [Abstract] [Full Text] [Related]

  • 6. Comparison of two guideline-concordant antimicrobial combinations in elderly patients hospitalized with severe community-acquired pneumonia.
    Wilson BZ, Anzueto A, Restrepo MI, Pugh MJ, Mortensen EM.
    Crit Care Med; 2012 Aug; 40(8):2310-4. PubMed ID: 22622401
    [Abstract] [Full Text] [Related]

  • 7. The impact of empiric antimicrobial therapy with a β-lactam and fluoroquinolone on mortality for patients hospitalized with severe pneumonia.
    Mortensen EM, Restrepo MI, Anzueto A, Pugh J.
    Crit Care; 2005 Dec 06; 10(1):R8. PubMed ID: 16420641
    [Abstract] [Full Text] [Related]

  • 8. Effectiveness of β-Lactam Monotherapy vs Macrolide Combination Therapy for Children Hospitalized With Pneumonia.
    Williams DJ, Edwards KM, Self WH, Zhu Y, Arnold SR, McCullers JA, Ampofo K, Pavia AT, Anderson EJ, Hicks LA, Bramley AM, Jain S, Grijalva CG.
    JAMA Pediatr; 2017 Dec 01; 171(12):1184-1191. PubMed ID: 29084336
    [Abstract] [Full Text] [Related]

  • 9. Clinical failure with and without empiric atypical bacteria coverage in hospitalized adults with community-acquired pneumonia: a systematic review and meta-analysis.
    Eljaaly K, Alshehri S, Aljabri A, Abraham I, Al Mohajer M, Kalil AC, Nix DE.
    BMC Infect Dis; 2017 Jun 02; 17(1):385. PubMed ID: 28576117
    [Abstract] [Full Text] [Related]

  • 10. Antibiotic treatment outcomes in community-acquired pneumonia.
    Çilli A, Sayıner A, Çelenk B, Şakar Coşkun A, Kılınç O, Hazar A, Aktaş Samur A, Taşbakan S, Waterer GW, Havlucu Y, Kılıç Ö, Tokgöz F, Bilge U.
    Turk J Med Sci; 2018 Aug 16; 48(4):730-736. PubMed ID: 30119147
    [Abstract] [Full Text] [Related]

  • 11. Antibiotic treatment strategies for community-acquired pneumonia in adults.
    Postma DF, van Werkhoven CH, van Elden LJ, Thijsen SF, Hoepelman AI, Kluytmans JA, Boersma WG, Compaijen CJ, van der Wall E, Prins JM, Oosterheert JJ, Bonten MJ, CAP-START Study Group.
    N Engl J Med; 2015 Apr 02; 372(14):1312-23. PubMed ID: 25830421
    [Abstract] [Full Text] [Related]

  • 12. Cardiac events after macrolides or fluoroquinolones in patients hospitalized for community-acquired pneumonia: post-hoc analysis of a cluster-randomized trial.
    Postma DF, Spitoni C, van Werkhoven CH, van Elden LJR, Oosterheert JJ, Bonten MJM.
    BMC Infect Dis; 2019 Jan 07; 19(1):17. PubMed ID: 30612559
    [Abstract] [Full Text] [Related]

  • 13. Respiratory fluoroquinolone monotherapy vs. β-lactam plus macrolide combination therapy for hospitalized adults with community-acquired pneumonia: A systematic review and meta-analysis of randomized controlled trials.
    Choi SH, Cesar A, Snow TAC, Saleem N, Arulkumaran N, Singer M.
    Int J Antimicrob Agents; 2023 Sep 07; 62(3):106905. PubMed ID: 37385561
    [Abstract] [Full Text] [Related]

  • 14. Guideline-concordant antibiotic use and survival among patients with community-acquired pneumonia admitted to the intensive care unit.
    Frei CR, Attridge RT, Mortensen EM, Restrepo MI, Yu Y, Oramasionwu CU, Ruiz JL, Burgess DS.
    Clin Ther; 2010 Feb 07; 32(2):293-9. PubMed ID: 20206787
    [Abstract] [Full Text] [Related]

  • 15. Impact of guideline-concordant antibiotics and macrolide/β-lactam combinations in 3203 patients hospitalized with pneumonia: prospective cohort study.
    Asadi L, Eurich DT, Gamble JM, Minhas-Sandhu JK, Marrie TJ, Majumdar SR.
    Clin Microbiol Infect; 2013 Mar 07; 19(3):257-64. PubMed ID: 22404691
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Empiric treatment in hospitalized community-acquired pneumonia. Impact on mortality, length of stay and re-admission.
    Reyes Calzada S, Martínez Tomas R, Cremades Romero MJ, Martínez Moragón E, Soler Cataluña JJ, Menéndez Villanueva R.
    Respir Med; 2007 Sep 07; 101(9):1909-15. PubMed ID: 17628462
    [Abstract] [Full Text] [Related]

  • 18. Comparative Efficacy of Beta-Lactams and Macrolides in the Treatment of Pediatric Pneumonia: A Systematic Review.
    Al Saeedy D, Gillani SW, Al-Salloum J, Moosvi A, Eissa M, Gulam SM.
    Curr Pediatr Rev; 2020 Sep 07; 16(4):307-313. PubMed ID: 32895041
    [Abstract] [Full Text] [Related]

  • 19. The order of administration of macrolides and beta-lactams may impact the outcomes of hospitalized patients with community-acquired pneumonia: results from the community-acquired pneumonia organization.
    Peyrani P, Wiemken TL, Metersky ML, Arnold FW, Mattingly WA, Feldman C, Cavallazzi R, Fernandez-Botran R, Bordon J, Ramirez JA.
    Infect Dis (Lond); 2018 Jan 07; 50(1):13-20. PubMed ID: 28699429
    [Abstract] [Full Text] [Related]

  • 20. Outcomes of Macrolide Deescalation in Severe Community-acquired Pneumonia.
    Hopkins TM, Juang P, Weaver K, Kollef MH, Betthauser KD.
    Clin Ther; 2019 Dec 07; 41(12):2540-2548. PubMed ID: 31676040
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.